Digital Health & Technology
-
January 04, 2024
Merck And Insurers Settle $1.4B Cyberattack Coverage Case
Merck has reached a settlement with its insurers over whether the pharmaceutical giant's "all-risk" property insurance covered $1.4 billion in losses stemming from the 2017 NotPetya attack or if its "hostile/warlike" exclusion applies.
-
January 03, 2024
AHA Says Data-Blocking Penalty Threatens Rural Hospitals
A proposed federal rule that establishes monetary penalties for information blocking may threaten the financial viability of small and rural hospitals, according to the American Hospital Association.
-
January 03, 2024
ACTS Retirement Data Breach Suit Settlement Gets Initial OK
A Pennsylvania federal judge gave preliminary approval Tuesday to a deal inked by ACTS Retirement Services Inc. to settle claims it failed to protect the personal information of nearly 21,000 people exposed in an April 2022 data breach.
-
January 03, 2024
BioXcel Execs Face Investor Suit Over Alzheimer's Drug Probe
Top brass at artificial intelligence-driven biopharmaceutical company BioXcel Therapeutics Inc. have been hit with a shareholder derivative suit alleging they took too long to disclose a U.S. Food and Drug Administration probe of its development of an Alzheimer's treatment and its lead clinical trial investigator's compliance issues.
-
January 03, 2024
FDA Seeks Comment On Ideas To Improve Agency Guidance
The U.S. Food and Drug Administration asked pharmaceutical companies, healthcare providers and others Wednesday to weigh in on how the agency can more quickly provide guidance on its interpretation of federal laws and regulations.
-
January 02, 2024
Colo. Doctor Says Biz Partner Stole Software For Own Co.
A Colorado doctor filed a lawsuit Tuesday against his former business partner over a failed medical software startup, alleging the business partner developed a competing platform and diverted revenue from the shared startup to his own company.
-
January 02, 2024
Lawsuit Says 23andMe Dragged Its Feet In Data Leak
A proposed class action in California federal court claims ancestry tracking company 23andMe took too long to respond to a data breach that affected millions of customers and targeted Ashkenazi Jewish users.
-
January 02, 2024
Chancery Dissolves Biomed Co. For 'Egregious' Conduct
Delaware's chancellor has ordered the dissolution of a company whose CEO and founder "lied, cheated, destroyed evidence and repeatedly ignored court orders" in a dispute pitting one brother against another over repayment of a $1.8 million loan for purportedly "Nobel Prize-worthy" biomedical research.
-
January 01, 2024
Sunset Of CMS' Remote Supervision Policy Draws Concern
As part of their New Year's resolutions, some leaders at U.S. healthcare associations are planning to push the federal government to restore a policy that allowed teaching physicians to remotely supervise residents as they care for Medicare patients in every part of the country.
-
December 28, 2023
Apple Watch Import Ban Put On Hold By Fed. Circ.
The Federal Circuit on Wednesday temporarily suspended a U.S. International Trade Commission ruling that banned imports of the Apple Watch in a patent dispute with Masimo Corp.
-
December 26, 2023
White House Won't Veto ITC Apple Watch Import Ban
The Biden administration said Tuesday that it will not veto a U.S. International Trade Commission decision banning imports of the Apple Watch in a patent dispute with Masimo Corp., days after the tech giant stopped selling some models of the popular devices due to the ruling.
-
December 21, 2023
5th Circ. Urged To Reject Retrial In DOJ's $140M Fraud Suit
A former medical device sales representative accused of running a $140 million healthcare fraud scheme in Houston with four other men told the Fifth Circuit on Thursday that he shouldn't be forced to face a retrial, writing that the government "knew or should have known" about alleged prosecutorial misconduct that forced a mistrial the first time around.
-
December 21, 2023
Becton Investors Seek OK Of $85M Deal Over Alaris Recall
A class of Becton Dickinson investors asked a New Jersey federal judge Thursday for his initial blessing on an $85 million settlement resolving securities fraud claims that the medical technology maker hid looming regulatory setbacks affecting the sales of its Alaris infusion pump, which Becton voluntarily recalled in 2020.
-
December 21, 2023
Top Government Contracts Of 2023: A Year In Review
This year saw the federal government conclude a $60 billion IT program for the U.S. Department of Veterans Affairs and a previously stalled $5.7 billion enterprise technology deal for the U.S. Air Force. But fatal errors with the VA's new $16 billion health records system forced it to pause the program. Here, Law360 takes a look back at some of the biggest government contracts from 2023.
-
December 21, 2023
Top North Carolina Cases Of 2023
A newly elected Republican majority on North Carolina's Supreme Court came out swinging early in 2023, overturning a decision by the previous year's liberal regime that held the state's election maps were gerrymandered and unconstitutional.
-
December 20, 2023
11 Deals That Shaped Healthcare And Life Sciences In 2023
The healthcare industry's appetite for mergers and acquisitions waned considerably this year, with both the number and size of deals falling well short of recent years. But that didn't make for a slow 2023, with segments like hospital systems showing renewed activity and major announcements in biotech that signaled a careful but growing appetite from the biggest players.
-
December 20, 2023
ITC Rejects Apple's Bid To Put Apple Watch Ban On Hold
The U.S. International Trade Commission on Wednesday denied Apple's request to stay an order that will soon halt imports of Apple Watch models found to infringe Masimo Corp. patents, unless it is vetoed by the White House.
-
December 20, 2023
FDA Offers Guide On Real-World Data For Device Submissions
Guidance from the U.S. Food and Drug Administration aims to clarify how the agency assesses real-world data and evidence when considering medical devices submitted for approval, addressing the use of data from wearable devices, among other issues.
-
December 20, 2023
Stimwave Buyer Can Enforce Sale In 'Disturbing' Domain Row
The buyer of Stimwave Technologies can force the medical device company's former CEO and her family to relinquish control of a domain name used to direct patients to information about faulty implants, a Delaware bankruptcy judge said Wednesday, calling the family's alleged efforts to redirect web traffic "immoral."
-
December 19, 2023
Indicted Stimwave CEO Hit With $41M Civil Suit From SEC
The U.S. Securities and Exchange Commission on Tuesday accused the former CEO of bankrupt medical device maker Stimwave Technologies of defrauding investors out of roughly $41 million, filing a civil suit against the embattled executive the same day federal prosecutors lodged a superseding indictment in her criminal case.
-
December 19, 2023
Fla. Nurse Convicted Of Medicare Fraud Faces Up To 21 Years
Federal prosecutors have asked a judge to sentence a nurse practitioner in Florida to roughly 17 to 21 years in prison for her role in a Medicare fraud ring, describing her as the nation's top prescriber of fraudulent genetic tests.
-
December 19, 2023
Philips Unit Inks $14.7M FCA Deal For Cardiac Monitoring Bills
Philips-owned BioTelemetry Inc. and its subsidiary will pay over $14.7 million to settle False Claims Act allegations that they inflated federal healthcare reimbursements for six years by inducing providers to bill for cardiac telemetry instead of the cheaper cardiac event monitoring services doctors had intended, the U.S. Department of Justice announced Monday.
-
December 19, 2023
Zymergen Gets Conditional OK For Ch. 11 Asset Sales
A Delaware bankruptcy judge on Tuesday signaled she would approve biotechnology company Zymergen's asset sales to two bidders as part of its Chapter 11 liquidation plan, under an agreement whereby the debtor's parent will acquire most of the business.
-
December 18, 2023
Claims Court Says Military Did Not Infringe Software Rights
A U.S. Court of Federal Claims judge has ruled that the U.S. Defense Health Agency did not infringe copyrights or breach the contract of a healthcare consulting services company because the business' registrations were invalid, and there was no proof of a deal.
-
December 18, 2023
Optum Group To Pay $160K After Patient Records Complaints
Optum Medical Care of New Jersey has agreed to pay $160,000 to resolve allegations it violated federal law by taking too long to release health records requested by patients and parents, federal officials say.
Expert Analysis
-
Where Health Care Enforcement Is Headed Under Biden
Early actions by President Joe Biden's administration signal a robust health care enforcement environment in which federal agencies will aggressively scrutinize pandemic-related and Medicare Advantage fraud, nursing homes, and medical technology, and False Claims Act activity will likely increase, say attorneys at Alston & Bird.
-
Mitigating Anti-Kickback Risks Of Health Tech Stock Warrants
While stock warrants are a practical way for the health technology industry to finance growth, companies should utilize statutory safe harbors to mitigate federal Anti-Kickback Statute compliance risks, which could arise from an improperly structured arrangement that encourages referral of business to a vendor, say Meenakshi Datta and Jon Zucker at Sidley.
-
ABA Remote Work Guide Raises Bar For Atty Tech Know-How
A recent American Bar Association opinion on lawyers' ethical duties of competence and confidentiality when working remotely should be viewed as part of a larger movement by which attorneys are being exhorted to develop competence in 21st century technology, say Jennifer Goldsmith at Ironshore and Barry Temkin at Mound Cotton.
-
3 Cybersecurity Questions To Ask Before A Remote Mediation
Lawyers preparing to mediate or arbitrate a case through videoconference should take steps to ensure they and their alternative dispute resolution providers are employing reasonable security precautions to protect digital client data and conform to confidentiality obligations, say F. Keith Brown and Michael Koss at ADR Systems.
-
Expect Aggressive Health Care Scrutiny From Mass. US Atty
As we await a new presidentially appointed U.S. attorney for Massachusetts, health business leaders and in-house counsel should reexamine their compliance structures, as the office will likely continue to prioritize enforcement efforts against both traditional areas of focus and pandemic-related fraud, say Jack Pirozzolo and Doreen Rachal at Sidley.
-
4 Areas Of Cyberattack Vulnerability For Law Firms
Recent data breaches involving Goodwin and Jones Day show that cyberattacks are very real threats to the legal profession, especially in the era of remote work, so law firms should revisit common business practices that expose them to unnecessary risks, says Ara Aslanian at Inverselogic.
-
Health Info Blocking Rule Creates Opportunities For Research
The U.S. Department of Health and Human Services' information blocking rule taking effect in April will provide researchers with a new tool for obtaining electronic health information, which could lead to a proliferation of new endeavors and insights, say attorneys at Ropes & Gray.
-
7 False Claims Act Enforcement Trends To Watch
False Claims Act enforcement statistics, along with anticipated enforcement priorities under the Biden administration, suggest that we will see a significant increase in FCA investigations and related litigation, targeting a widening array of industries and categories of defendants, say attorneys at Winston & Strawn.
-
Data Compliance Issues For Cos. Making, Using Vaccine Apps
To manage privacy concerns with COVID-19 vaccine verification tools, developers should look to the Federal Trade Commission's Fair Information Practice Principles to build secure applications consistent with U.S. privacy laws, and employers should ensure that notice, recordkeeping and retention requirements are in place, say attorneys at Troutman Pepper.
-
A Look At Factors Influencing Medical Device Approval Speed
Analysis indicates that several factors affect U.S. Food and Drug Administration medical device approval times, and that FDA mechanisms for speeding up the process are not especially effective, say analysts at Emerging Health.
-
Prepare For NY Data Privacy Law To Catch Up To Calif.
The proposed New York Data Accountability and Transparency Act, along with last year's SHIELD Act, means that the state may soon have comprehensive privacy laws that rival California's, and all businesses with New York customers should take several important compliance steps to prepare, say attorneys at Gibson Dunn.
-
Predictions For How Telehealth Law Will Evolve In 2021
Following the significant activity COVID-19 brought to telemedicine and digital health policy in 2020, legislators will likely continue reducing barriers to virtual care this year, but regulators' enforcement efforts will rise as well, says Nathaniel Lacktman at Foley & Lardner.
-
Lessons From 2020 Life Sciences Securities Class Actions
Life sciences companies can draw important insights from the many dismissal opinions that federal courts issued during 2020 in securities actions arising from adverse U.S. Food and Drug Administration actions and clinical development setbacks, say Yvonne Puig and Peter Stokes at Norton Rose.